China NT Pharma Group Company Limited (HKG:1011)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.4000
-0.0050 (-1.23%)
Aug 26, 2026, 3:32 PM HKT

HKG:1011 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
11.917.229.621.525.939.44
Short-Term Investments
3.25-----
Cash & Short-Term Investments
15.157.229.621.525.939.44
Cash Growth
227.02%-24.96%533.09%-74.37%-37.19%22.73%
Accounts Receivable
12.121.8-10.0533.6712.45
Other Receivables
-0.10.080.5520.7821.52
Receivables
12.121.90.0810.654.4533.98
Inventory
2.060.40.17-10.3232.01
Prepaid Expenses
-4.575.090.11--
Other Current Assets
-1.271.230.052.74192.28
Total Current Assets
29.3315.3616.1912.2873.43267.7
Property, Plant & Equipment
4.120.630.540.94379.72222.37
Long-Term Investments
328.99331.36317.28313.55277.58278.46
Other Intangible Assets
191.84--0.2274.98186.83
Other Long-Term Assets
--0.072.16--
Total Assets
642.85347.35334.08329.121,006955.36

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
4.092.660.50.978.4844.63
Accrued Expenses
140.68133.25143.99118.64170.56100.1
Short-Term Debt
-252.52313.81286.09348.07140.45
Current Portion of Long-Term Debt
332.3263.6153.6954.62476.97476.38
Current Portion of Leases
2.670.490.340.630.951.61
Current Income Taxes Payable
---0.1225.0513.98
Current Unearned Revenue
----4.86.1
Other Current Liabilities
166.43168.58212.74204.01134.82112.73
Total Current Liabilities
646.19621.1725.07665.091,170895.97
Long-Term Debt
--7.993.22-213.29
Long-Term Leases
-0.090.130.380.460.39
Long-Term Deferred Tax Liabilities
47.96---77.2257.08
Total Liabilities
694.15621.18733.18668.691,2471,167

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.0100000
Additional Paid-In Capital
-1,8911,8061,8061,7591,759
Retained Earnings
--2,566-2,549-2,498-2,639-2,537
Comprehensive Income & Other
-111.26401.12343.89351.98638.24566.86
Total Common Equity
-111.26-273.62-399.11-339.57-241.66-211.38
Minority Interest
59.96-0.21----
Shareholders' Equity
-51.3-273.83-399.11-339.57-241.66-211.38
Total Liabilities & Equity
642.85347.35334.08329.121,006955.36

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
334.99316.7375.95344.94826.45832.11
Net Cash (Debt)
-319.84-309.48-366.33-343.42-820.52-822.67
Net Cash Growth
------
Net Cash Per Share
-0.43-0.50-1.39-1.44-4.32-4.35
Filing Date Shares Outstanding
821.49674.25264.09264.09190.46190.46
Total Common Shares Outstanding
821.49674.25264.09264.09190.46190.46
Working Capital
-616.86-605.73-708.88-652.81-1,096-628.27
Book Value Per Share
-0.14-0.41-1.51-1.29-1.27-1.11
Tangible Book Value
-391.68-273.62-399.11-339.76-516.64-398.21
Tangible Book Value Per Share
-0.48-0.41-1.51-1.29-2.71-2.09
Buildings
----363.03207.26
Machinery
-0.060.020.1687.2738.16
Construction In Progress
----5.831.5
Leasehold Improvements
-0.11--9.739.25